Product Information
TETRABENAZINE 12.5 MG TABLET is a generic product labeled by Slate Run Pharmaceuticals LLC, priced at $0.8043 per EA under NDC 70436010109. Its NADAC has been published 170 times since Feb 22, 2023.
FDA first approved this application on Jan 22, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the tetrabenazine market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
12.5 mg/1
Manufacturer
Slate Run Pharmaceuticals LLCNDC
70436010109
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
TETRABENAZINEApproval Type
Generic (ANDA)
FDA Application
ANDA213316FDA Approved
1/22/2020
TE Code
AB
On Market Since
3/2/2020
Pharmacological Classes
Price Statistics
The NADAC for TETRABENAZINE 12.5 MG TABLET has been published 170 times since Feb 22, 2023, and over the history we have for it it has declined 69.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8043 per EA |
|---|---|
| All-time high | $3.2465 (Dec 13, 2023) |
| All-time low | $0.7645 (Sep 17, 2025) |
| 52-week high | $0.8043 |
| 52-week low | $0.7645 |
| Median price | $1.5454 |
| Average price | $1.7473 |
| Largest weekly change | -63.3% (Dec 20, 2023) |
| Weeks tracked | 170 |
| Tracking since | Feb 22, 2023 |
1W
N/A
1M
N/A
3M
N/A
6M
+4.7%
1Y
+1.9%
3Y
-75.2%
5Y
N/A
All
-69.0%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TETRABENAZINE 12.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TETRABENAZINE 12.5 MG TABLET, manufactured by Slate Run Pharmaceuticals LLC, is $0.8043 per EA (NDC 70436010109), effective May 20, 2026.
How has the price of TETRABENAZINE 12.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for TETRABENAZINE 12.5 MG TABLET has declined 69.0%. It has been tracked across 170 weekly CMS publications since Feb 22, 2023.
What are the highest and lowest recorded NADAC prices for TETRABENAZINE 12.5 MG TABLET?
Since Feb 22, 2023, the NADAC for TETRABENAZINE 12.5 MG TABLET has ranged from a low of $0.7645 (Sep 17, 2025) to a high of $3.2465 (Dec 13, 2023), with a median of $1.5454 per EA.
Are there cheaper alternatives to TETRABENAZINE 12.5 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TETRABENAZINE 12.5 MG TABLET, is $0.7604 per EA — about 5% below TETRABENAZINE 12.5 MG TABLET.
Who manufactures TETRABENAZINE 12.5 MG TABLET?
TETRABENAZINE 12.5 MG TABLET (NDC 70436010109) is labeled by Slate Run Pharmaceuticals LLC, and CMS classifies it as a generic product.